Restructuring Charges (Tables)

9 Months Ended

Sep. 30, 2013

Schedule of restructuring and related costs

During the nine months ended September 30, 2013, the Company implemented restructurings of its workforce to better focus the Company's organizational structure, increase efficiency and concentrate financial resources on its clinical development program and European commercialization activity. This resulted in a reduction in the Company's workforce by 29 employees. As a result of termination benefits given to the impacted employees, the Company incurred a total cost of approximately $2.6 million which is reflected on the Condensed Consolidated Statements of Operations in both "Selling, general and administrative expenses" and "Research and development expenses", as appropriate. The $1.7 million in accrued severance expenses at September 30, 2013 is included in both Current "Accrued expenses" and Long-term Accrued expenses on the Condensed Consolidated Balance Sheets.

(in thousands)	September 30, 2013
Severance and restructuring expenses	$	2,628
Restructuring expenses paid by September 30, 2013		(883	)
Total restructuring expenses accrued as of September 30, 2013	$	1,745

- Definition

Tabular disclosure of restructuring and related costs by type of restructuring including the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost.

+ References+ Details